Reply To: US Weekly IPO and SPAC Monitor: Intel’s Mobileye, Biotech’s ASP Isotopes and Intensity Therapeutics

#45900
MoneyNeverSleeps
Participant

Mobileye Global (MBLY) (NasdaqGS) files amended S-1 for IPO; expects to offer 41 mln shares between $18-$20 Intel sold off on the lower valuation